<DOC>
	<DOCNO>NCT00001110</DOCNO>
	<brief_summary>The purpose study see : ( 1 ) amount HIV lungs compare blood ; ( 2 ) HAART reduce amount HIV lung ; ( 3 ) HAART reduce lung inflammation HIV-infected patient . Lung-cell inflammation HIV-infected patient probably cause HIV infection cell . The amount inflammation may correspond amount HIV ( viral load ) lung ( i.e. , mild inflammation indicate low amount HIV ; severe inflammation indicate high amount HIV ) . HAART use decrease amount HIV body . If HAART able decrease viral load lung , also able decrease lung-cell inflammation patient .</brief_summary>
	<brief_title>Effect Anti-HIV Therapy ( HAART ) HIV Levels Lungs Lung Cell Inflammation HIV-Infected Patients</brief_title>
	<detailed_description>Lymphocytic alveolitis HIV-infected patient probably represent local immune response HIV-infected cell lung . The intensity lymphocytic alveolitis may therefore reflect viral load lung . If , treatment reduces viral load lung ( e.g. , HAART ) also decrease number cytotoxic T lymphocytes ( CTLs ) alveolar space return pulmonary immune response toward normal . Patients stratify CD4 count : le 200 cells/mm3 200 - 500 cells/mm3 . BAL perform blood sample collect prior initiation HAART 1 6 month HAART . If patient detectable HIV lung 6 month HAART , patient ask submit optional fourth BAL 12 month HAART . BAL fluid cell analyze HIV viral load , percent lymphocyte , lymphocyte subset . Responses lung compare simultaneous change variable find peripheral blood . Each patient serve his/her control .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Are least 18 year old . Have CD4 count less equal 500 cells/mm3 HIV RNA level great equal 5000 copies/ml . Are start regimen least 3 antiHIV drug ( HAART ) . Exclusion Criteria Patients eligible study : Have ever receive protease inhibitor ( PIs ) nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) . Have sign symptom lung disease past 30 day ( pneumonia , bronchitis , emphysema , asthma , severe cough , severe shortness breath ) . Have receive certain medication , include HIV vaccine . Have receive chemotherapy within 30 day prior study entry , cancer require chemotherapy . Are pregnant beyond first 3 month pregnancy Week 24 ( Month 6 ) study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Lung</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Viremia</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Bronchoalveolar Lavage Fluid</keyword>
</DOC>